| http://www.w3.org/ns/prov#value | - Among studies that included patients with other forms of Cushing's syndrome, response rates were 53% to 88% for ketoconazole (three studies), 70% for mitotane (one study), 57% for metyrapone (one study), and 38% to 60% for mifepristone (one study).
|
